NCBI STANDARD_TERMS : CROSS REFERENCE
=====================================
MedGen uses these standard terms from NCBI sources
http://www.ncbi.nlm.nih.gov/medgen/docs/definitionsources/

|
|
|
Molecular Consequence
----------------------------------
#. 2KB upstream variant
#. 3 prime UTR variant
#. 5 prime UTR variant
#. 500B downstream variant
#. exon_loss
#. frameshift variant
#. inframe_variant
#. intergenic_variant
#. intron
#. missense variant
#. non-coding transcript variant
#. nonsense
#. splice acceptor variant
#. splice donor variant
#. start lost
#. stop lost
#. synonymous variant

|
|

Functional Consequence
----------------------------------
#. amphigoric amino acid deletion
#. complete gene deletion
#. cryptic splice acceptor activation
#. cryptic splice donor activation
#. decreased_translational_product_level
#. effect on RNA abundance
#. effect on RNA splicing
#. effect on promoter activity
#. effect on protein abundance
#. effect on protein activity
#. effect on protein degradation
#. effect on protein subcellular localization
#. exon loss
#. has functional consequence
#. initiation codon change
#. missing RNA
#. missing protein
#. no known functional consequence
#. polypeptide_partial_loss_of_function
#. probably has functional consequence
#. probably no functional consequence
#. protein gain of function
#. protein loss of function
#. unknown functional consequence
#. variation affecting RNA

|
|

Allele_origin (+dbSNP)
----------------------------------
#.  biparental
#.  de novo
#.  germline
#.  inherited
#.  maternal
#.  not-reported
#.  paternal
#.  somatic
#.  tested-inconclusive
#.  uniparental
#.  unknown

|
Analyte_category (GTR)
----------------------------------
#.  Chromosome Rearrangements
#.  Copy Number Variations
#.  Enzymes
#.  Full genome
#.  Haplotypes
#.  Metabolites
#.  Nucleotide Sequence Variations


|
CAP_test_categories (GTR)
----------------------------------
#.  Alpha-1 Antitrypsin (SERPINA1) Genotyping
#.  Apolipoprotein E Genotyping
#.  Biochemical Genetics
#.  Cytogenetics
#.  Cytogenomic Microarray Analysis
#.  Defective DNA Mismatch Repair/HNPCC
#.  Fluorescence in Situ Hybridization (FISH)
#.  Fluorescence in Situ Hybridization (FISH) for Paraffin-Embedded Tissue
#.  Glioma
#.  HLA Molecular Typing
#.  HLA-B27 Typing
#.  Hemoglobinopathies, Molecular Methods
#.  In Situ Hybridization
#.  Inherited Metabolic Diseases
#.  Minimal Residual Disease
#.  Molecular Genetics
#.  Molecular Genetics Sequencing
#.  Molecular Hematologic Oncology
#.  Multigene Tumor Panel
#.  Neoplastic Cellularity
#.  Pharmacogenetics
#.  Red Blood Cell Antigen Genotyping
#.  Rett Syndrome (MECP2) Genotyping
#.  Sarcoma Translocation
#.  Solid Tumors - Other
#.  Thrombophilia Mutations

|
Clinical_significance (GTR +ClinVar)
-------------------------------------
#.  Pathogenic
#.  Likely pathogenic
#.  drug response
#.  confers sensitivity
#.  risk factor
#.  association
#.  Uncertain significance
#.  Likely benign
#.  Benign
#.  protective
#.  not provided
#.  conflicting data from submitters
#.  other

|

Clinical_utility_categories (GTR)
----------------------------------
#.  Avoidance of invasive testing
#.  Establish or confirm diagnosis
#.  Guidance for management
#.  Guidance for selecting a drug therapy and/or dose
#.  Lifestyle planning
#.  Predictive risk information for patient and/or family members
#.  Reproductive decision-making
#.  Other
#.  Sufficient research has not been conducted to demonstrate the utility of the test

| 
Mode_of_inheritance (+ClinVar, +HPO, GTR)
-----------------------------------------
#.  HP:0000006 Autosomal dominant inheritance
#.  HP:0000007 Autosomal recessive inheritance 
#.  Autosomal unknown
#.  Codominant
#.  HP:0003743: Genetic anticipation
#.  HP:0001427: Mitochondrial inheritance
#.  HP:0001470: Sex-limited autosomal dominant
#.  HP:0001428: Somatic mutation
#.  HP:0003745: Sporadic
#.  HP:0001423: X-linked dominant inheritance
#.  HP:0001417: X-linked inheritance
#.  HP:0001419: X-linked recessive inheritance
#.  HP:0001450: Y-linked inheritance
#.  Other

|

population_group
----------------------------------
#.  MedGen:C0085756 African American
#.  MedGen:C1515945 American Indian or Alaska Native
#.  MedGen:C0337704 Ashkenazi Jew
#.  MedGen:C0043157 Causasians
#.  MedGen:C0152035 Chinese 
#.  MedGen:C0682087 European Caucasoid
#.  MedGen:C0019576 Hispanic Americans
#.  MedGen:C1513907 Native Hawaiian or Other Pacific Islander
#.  MedGen:C0238697 South East Asian
#.  MedGen:C0682086 mixed ethnic group
#.  none
#.  unspecified

| 
CAP_test_codes
----------------------------------
#.  52 codes in total, such as "EGFR"


|

HPO Frequency
--------------


Percent of patients
very rare1 %
rare	5 %
occasional
7.5 %
frequent
33 %
typical
50 %
variable	? (prob. 30%-70%)
common
75 %
hallmark
90 %
obligate
100 %
